Insulin therapy for adult patients with type 2 diabetes mellitus: A position statement of the korean diabetes association, 2017

Byung Wan Lee; Jin Hwa Kim; Seung Hyun Ko; Kyu Yeon Hur; Nan Hee Kim; Sang Youl Rhee; Hyun Jin Kim; Min Kyong Moon; Seok O. Park; Kyung Mook Choi

doi:10.3904/kjim.2017.314

Insulin therapy for adult patients with type 2 diabetes mellitus: A position statement of the korean diabetes association, 2017

Byung Wan Lee, Jin Hwa Kim, Seung Hyun Ko, Kyu Yeon Hur, Nan Hee Kim, Sang Youl Rhee, Hyun Jin Kim, Min Kyong Moon, Seok O. Park, Kyung Mook Choi

Department of Internal Medicine

Research output: Contribution to journal › Review article › peer-review

4 Citations (Scopus)

Abstract

The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

Original language	English
Pages (from-to)	967-973
Number of pages	7
Journal	Korean Journal of Internal Medicine
Volume	32
Issue number	6
DOIs	https://doi.org/10.3904/kjim.2017.314
Publication status	Published - 2017 Nov

Bibliographical note

Publisher Copyright:
© 2017 The Korean Association of Internal Medicine

All Science Journal Classification (ASJC) codes

Internal Medicine

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.3904/kjim.2017.314

Cite this

@article{795fa1df75454c48a3696e5cabf5e767,

title = "Insulin therapy for adult patients with type 2 diabetes mellitus: A position statement of the korean diabetes association, 2017",

abstract = "The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.",

keywords = "Clinical practice guideline, Diabetes mellitus, Hypoglycemic agents, Insulin, Korea, Type 2",

author = "Lee, {Byung Wan} and Kim, {Jin Hwa} and Ko, {Seung Hyun} and Hur, {Kyu Yeon} and Kim, {Nan Hee} and Rhee, {Sang Youl} and Kim, {Hyun Jin} and Moon, {Min Kyong} and Park, {Seok O.} and Choi, {Kyung Mook}",

note = "Publisher Copyright: {\textcopyright} 2017 The Korean Association of Internal Medicine",

year = "2017",

month = nov,

doi = "10.3904/kjim.2017.314",

language = "English",

volume = "32",

pages = "967--973",

journal = "Korean Journal of Internal Medicine",

issn = "1226-3303",

publisher = "Korean Association of Internal Medicine",

number = "6",

}

TY - JOUR

T1 - Insulin therapy for adult patients with type 2 diabetes mellitus

T2 - A position statement of the korean diabetes association, 2017

AU - Lee, Byung Wan

AU - Kim, Jin Hwa

AU - Ko, Seung Hyun

AU - Hur, Kyu Yeon

AU - Kim, Nan Hee

AU - Rhee, Sang Youl

AU - Kim, Hyun Jin

AU - Moon, Min Kyong

AU - Park, Seok O.

AU - Choi, Kyung Mook

PY - 2017/11

Y1 - 2017/11

N2 - The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

AB - The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel and traditional insulin analogues has also been accumulated. Following global trends, many results of clinical trials, especially concerning the clinical efficacy and safety of insulin therapy, have been published about Korean patients with T2DM. After a systematic search of recent evidence, the KDA updated and modified its clinical practice recommendations regarding the initiation, choice, and intensification of insulin and created an insulin treatment algorithm for the first time to guide physicians caring for adult Korean patients with T2DM.

KW - Clinical practice guideline

KW - Diabetes mellitus

KW - Hypoglycemic agents

KW - Insulin

KW - Korea

KW - Type 2

UR - http://www.scopus.com/inward/record.url?scp=85034618483&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034618483&partnerID=8YFLogxK

U2 - 10.3904/kjim.2017.314

DO - 10.3904/kjim.2017.314

M3 - Review article

C2 - 29057642

AN - SCOPUS:85034618483

SN - 1226-3303

VL - 32

SP - 967

EP - 973

JO - Korean Journal of Internal Medicine

JF - Korean Journal of Internal Medicine

IS - 6

ER -

Insulin therapy for adult patients with type 2 diabetes mellitus: A position statement of the korean diabetes association, 2017

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this